Daugbjerg Madsen Group – SecretoDynamics (SecDyn)

The SecretoDynamics group studies how impaired protein secretion in endocrine and exocrine cells drives systemic and tissue-specific metabolic disorders, focusing on how complex protein O-glycosylation contributes to type 2 diabetes.

Research focus

Compromised secretion from gastrointestinal organs underlies prevalent diseases of the gut such as diabetes mellitus and inflammatory bowel disease. While clinically, they commonly present as inflamatory or autoimmune diseases, the cellular basis for immune-mediated organ dysfunction is poorly understood.

Specialized secretory cells within these organs produce a large amount of proteins, such as digestive enzymes (exocrine) or hormones (endocrine), which are stored in granules as cargo. The cells release the cargoes through regulated secretion to perform and coordinate digestive, anti-inflammatory, protective, and metabolic functions.

Group leader

Additional research focus

This extraordinary protein production load is prone to error when the organs are under metabolic stress, however, the mechanisms behind how packaging and release of regulated secretory proteins are orchestrated remains unclear.

We have identified that protein O-glycosylation, a post-translational modification, is maintaining correct cargo loading in granules, and that this modification is susceptible to metabolic stress, predisposing tissues for secretory dysfunction and inflammation.

To explore this, we combine animal models, ex vivo and in vitro methods to uncover the regulating mechanisms for exocrine and endocrine secretion that are influence by metabolic stress to reach our ultimate goal: identifying biomarkers and interventions that can aid in the prevention of diseases in secretory organs.

2-photon image of the pancreas in a living mouse (Green: Membranes, Magenta: Mitochondria, Blue: Cytosol).

Current Research

Dysregulated O-Glycosylation Sets the Prediabetic Proinflammatory Stage
In this project, we will study:

  • O-Glycan Changes in Relation to Prediabetic Progression
  • Pancreatic Exocrine / Endocrine Crosstalk
  • O-Glycan-mediated Inflammatory Control in the Pancreas
  • The role of O-glycosylation in Endocrine & Exocrine Packaging.

About the project

Type 2 diabetes develops gradually and is closely linked to inflammation in the pancreas, but the early events that trigger this process locally are not well understood.

This project studies how sugar molecules attached to proteins — a process called glycosylation — help control communication between different pancreatic cell types and regulate inflammation. I have data suggesting that a high-fat diet alters these sugar structures in the pancreas: in digestive enzyme–producing cells, this causes enzymes to leak into insulin-producing regions, triggering inflammation.

At the same time, insulin-producing cells lose protective sugar signals that normally keep inflammation down. Together, these changes promote inflammation and damage insulin-producing cells.

Using advanced imaging techniques, this project will track how these changes develop over time and test if restoring protective sugar signals can reduce inflammation as a strategy to prevent or slow the development of type 2 diabetes.

Read about the project 'Dysregulated O-Glycosylation Sets the Prediabetic Proinflammatory Stage' on the Novo Nordisk Foundation website.

Techniques

  • Animal models (e.g. diet-induced obese)
  • Multiplex iterative staining of tissues
  • Spatially-resolved ‘Omics
  • In vitro phase separation
  • Confocal / spinning disk microscopy
  • 3D clearing of tissues & wholemount imaging
  • Intravital Microscopy (Fluorescence microscopy in living rodents).

Group members